Stay updated on Pembrolizumab for Advanced Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedPubMed publications note updated to say they are automatically filled from PubMed, and the revision indicator now shows v3.3.2 (replacing v3.2.0).SummaryDifference0.1%

- Check26 days agoChange DetectedThe government funding lapse banner at the top of the ClinicalTrials.gov page has been removed, a non-significant change that does not affect study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedNo significant changes to core study information (eligibility criteria, endpoints, enrollment, or contacts); only minor visual/layout tweaks to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference3%

- Check78 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1) and the Back to Top element has been removed, indicating a minor UI/navigation update.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab for Advanced Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page.